Related Experiment Video
Updated: Sep 25, 2025

05:49
Protein Engineering by Yeast Surface Display
Published on: November 29, 2024
2.0K
Isolating Anti-amyloid Antibodies from Yeast-Displayed Libraries
Alec A Desai1,2, Jennifer M Zupancic1,2, Matthew D Smith1,2
1Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, USA.
Methods in Molecular Biology (Clifton, N.J.)
|April 28, 2022
Summary
Researchers developed a yeast surface display method to isolate and improve antibodies targeting misfolded amyloid proteins. This technique helps create specific antibodies for treating neurodegenerative diseases like Alzheimer's and Parkinson's.
Area of Science:
- Biochemistry
- Immunology
- Neuroscience
Background:
- Conformational antibodies targeting amyloid proteins are crucial for diagnosing and treating protein aggregation disorders such as Alzheimer's and Parkinson's diseases.
- Generating these specific antibodies is challenging due to the complex and insoluble nature of amyloid antigens.
Purpose of the Study:
- To establish systematic methods for isolating and affinity maturing anti-amyloid antibodies using yeast surface display.
- To develop antibodies with high conformational specificity for amyloid structures.
Main Methods:
- Utilizing yeast surface display for antibody library screening.
- Employing magnetic-activated cell sorting (MACS) for positive selection of amyloid-binding antibodies and negative selection against disaggregated antigens.
- Performing affinity maturation via targeted CDR mutagenesis on selected antibody clones.
Main Results:
- Successful isolation of antibody clones with high specificity for amyloid conformations.
- Demonstration of yeast surface display combined with MACS as an effective strategy for anti-amyloid antibody generation.
- Validation of affinity maturation to enhance antibody binding properties.
Conclusions:
- The described yeast surface display and MACS-based approach provides a robust platform for generating conformationally specific anti-amyloid antibodies.
- This method facilitates the development of novel diagnostics and therapeutics for protein aggregation disorders.
- Targeted affinity maturation further refines antibody efficacy for biomedical applications.

